Gain Therapeutics, Inc. - Common Stock — 貸借対照表 (NASDAQ:GANX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 38.99 M24.1 M18.61 M12.12 M22.82 M 負債合計 4.17 M5.22 M6.03 M4.78 M4.25 M 純資産合計 34.82 M18.88 M12.58 M7.34 M18.56 M 負債および純資産合計 38.99 M24.1 M18.61 M12.12 M22.82 M 有利子負債合計 590.47 K495.26 K449.05 K328.33 K400.95 K 純負債 590.47 K495.26 K-16.35 M328.33 K-20.54 M

ニュース

ゲイン・セラピューティクス、パーキンソン病バイオマーカーの81%減少を報告

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

ロス/MKM、ゲイン・セラピューティクスの目標株価を臨床試験データ好調で10ドルに引き上げ

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy

H.C. ワインライト社、治験データ発表を前にゲイン・セラピューティクス株の買い推奨を維持

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data

ゲイン・セラピューティクス、3,550万ドルの株式公募のための目論見書補足を提出

Gain Therapeutics files prospectus supplement for $35.5 million stock offering